Incyte
INCY
#1110
Rank
ยฃ15.10 B
Marketcap
ยฃ76.96
Share price
2.05%
Change (1 day)
31.06%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ1.26 Billion

According to Incyte's latest financial reports the company's total liabilities are ยฃ1.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ1.59 B27.31%
2023-12-31ยฃ1.24 B2.8%
2022-12-31ยฃ1.21 B41.07%
2021-12-31ยฃ0.86 B23.7%
2020-12-31ยฃ0.69 B10.29%
2019-12-31ยฃ0.63 B11.4%
2018-12-31ยฃ0.56 B14.05%
2017-12-31ยฃ0.49 B-49.68%
2016-12-31ยฃ0.98 B75.08%
2015-12-31ยฃ0.56 B0.06%
2014-12-31ยฃ0.56 B13.09%
2013-12-31ยฃ0.49 B59.51%
2012-12-31ยฃ0.31 B-12.6%
2011-12-31ยฃ0.35 B-4.49%
2010-12-31ยฃ0.37 B-25.61%
2009-12-31ยฃ0.50 B62.85%
2008-12-31ยฃ0.30 B41.13%
2007-12-31ยฃ0.21 B-2.14%
2006-12-31ยฃ0.22 B-1.89%
2005-12-31ยฃ0.22 B-0.07%
2004-12-31ยฃ0.22 B81.38%
2003-12-31ยฃ0.12 B-19.17%
2002-12-31ยฃ0.15 B-14.9%
2001-12-31ยฃ0.18 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
ยฃ60.44 B 4,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.39 B-68.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ68.37 B 5,324.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 6,786.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
ยฃ0.23 B-81.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.24 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ46.94 B 3,624.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
ยฃ54.33 M-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
ยฃ0.10 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA